Results
Novyra Pharmachem FY26 Net Loss of ₹5.37 Crore
Board approved audited standalone financial results for FY26 ending March 31, 2026, reporting a net loss of ₹5.37 crore.
Company reported negative other equity of ₹5.71 crore and total assets of ₹1.46
